FORM 8-K

Company

Lexaria Bioscience Corp.

Filed

March 21, 2024

Period of Report

March 15, 2024

Accession Number

0001640334-24-000446

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →